Let's say tt-034 early results underwhelm and management state they need
the lab to go re-tweak the design for another 18months, and a week later (after the remaining pillows have been thrown out the cot)
Calimmune report very encouraging HIV trial results.
There's another avenue to our proof of concept for the tech, and likely enough support to fund the re-tweaking of tt-034 and line up HBV for a red hot own it outright curative shot.
- Forums
- ASX - By Stock
- BLT
- Maxim's Strong Incentive...
Maxim's Strong Incentive..., page-25
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online